查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439361

全球射頻消融設備市場：洞察、競爭格局、市場預測：2030 年

Radiofrequency Ablation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球射頻消融器材市場規模達36.4億美元。預計到 2030 年，該市場將達到 61.9 億美元，2024 年至 2030 年的預測期間複合年增長率為 9.37%。心血管疾病和癌症等慢性病盛行率的增加、老年人口的增加以及產品開發和設計改進的技術進步推動了射頻消融設備需求的成長。

由於心血管疾病等各種慢性疾病的盛行率不斷上升，射頻消融設備市場的市場收入不斷增加。根據世界衛生組織 (WHO) (2023) 提供的情況說明書，心血管疾病 (CVD) 是全世界死亡的主要原因，估計每年有 1,790 萬人死於該疾病。CVD 被歸類為一組專門影響心臟和血管的疾病。CVD包括冠狀動脈心臟病、風濕性心臟病、腦血管疾病。此外，根據世界心臟基金會引用的數據，到 2030 年，歐盟將有約 1,400 至 1,700 萬人患有心房顫動。上述消息人士進一步指出，美國患有心房顫動的人數達1,200萬，而射頻消融是治療心房顫動的常用方法。因此，全球心房顫動等心血管疾病盛行率的上升將導致射頻消融設備的需求增加，從而推動全球射頻消融設備市場的成長。

該報告研究了全球射頻消融設備市場，並提供了市場概述，包括按產品類型、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第一章射頻消融設備市場報告簡介

第二章射頻消融設備市場概要

第三章 法規與專利分析

  • 美國
  • 歐洲
  • 日本

第四章射頻消融器械市場主要因素分析

  • 射頻消融設備市場的驅動因素
  • 射頻消融器械市場的抑制因素與挑戰
  • 射頻消融設備的市場機會

第五章射頻消融器械市場波特五力分析

第六章 COVID-19對射頻消融器械市場的影響分析

第七章 射頻消融器材市場概況

  • 按產品類型
  • 按用途
  • 按最終用戶
  • 按地區

第八章高頻消融器械市場全球公司份額分析－3~5家主要公司

第九章射頻消融設備市場公司與產品概況

  • BIOTRONIK Schweiz AG
  • Medtronic
  • Abbott
  • Olympus
  • Stryker
  • Boston Scientific Corporation
  • AngioDynamics
  • CONMED Corporation
  • Lepu Medical Technology (Beijing) Co.,Ltd
  • Arthrex Inc.
  • STARmed Co., Ltd.,
  • HOLOGIC, INC
  • Baylis Medical Company, Inc
  • Medical Devices Business Services, Inc. (Johnson & Johnson)
  • Smith & Nephew
  • Sutter Medizintechnik GmbH
  • Bramsys
  • RF Medical Co., Ltd
  • OSYPKA AG
  • Avanos Medical, Inc.

第10章 項目方法

第11章 KOL觀點

第12章 DelveInsight服務內容

第13章 免責聲明

第 14 章關於 DelveInsight

Product Code: DIMDCL0157

Radiofrequency Ablation Devices Market By Product Type (Rf Generators, Rf Catheters, Rf Electrodes, And Others), By Application (Cardiology, Oncology, Pain Management, And Others), By End User (Hospitals, Specialty Clinics, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic diseases such as atiral fibrillation and various cancers.

Global Radiofrequency Ablation Devices Market was valued at USD 3.64 billion in 2023, growing at a CAGR of 9.37% during the forecast period from 2024 to 2030 to reach USD 6.19 billion by 2030. The demand for radiofrequency ablation devices is witnessing growth due to the growing prevalence of chronic diseases such as cardiovascular diseases, cancers, rising geriatric population, and technological advancements in product development and design improvement.

Radiofrequency Ablation Devices Market Dynamics:

The radiofrequency ablation devices market is witnessing an increase in market revenue owing to the rising prevalence of various chronic diseases such as cardiovascular diseases. As per the factsheet provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, where in this group of disease account for an estimated 17.9 million lives each year. CVDs are classified as a group of disorders that specifically affect the heart and blood vessels. Some of CVDs include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other conditions. Additionally, the data cited by the World Heart Foundation stated that by 2030, near about 14-17 million people in the European Union will be living with atrial fibrillation. The aforementioned source further stated the numbers for atrial fibrillation to reach 12 million in the United States. Radiofrequency ablation is a popular method which is employed in the AFib treatment. Therefore, the rising global prevalence of cardiovascular diseases such as atrial fibrillation would lead to the increase in the demand for radiofrequency ablation devices, thereby aiding in the global radiofrequency ablation devices market growth.

Another key factor responsible for the growth of the radiofrequency ablation devices market is the rising prevalence of various cancers. Liver cancer is one of the commonest types of cancers where radiofrequency ablation is used as one of the treatment approaches. As per the GLOBOCAN 2020 study, in 2020, there were approximately 905,677 new cases and about 830,180 deaths associated with liver cancer respectively across the globe. Even though radiofrequency ablation is not the mainstay treatment for cancers, it is often used as either an adjunctive treatment or is suggested on case-to-case basis. Therefore, the rising prevalence of cancers of different etiologies are also expected to contribute in the growing demand for radiofrequency ablation devices, eventually taking the radiofrequency ablation devices market forward during the forecast period.

However, radiofrequency ablation procedure-related risks as well as limited ablation zone in cancer treatment may prove to be certain restraints to the radiofrequency ablation devices market growth.

In addition to the previously mentioned factors, the radiofrequency ablation devices market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for radiofrequency ablation devices in the market as various RF ablation procedures were deemed non-essential during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for RF ablation devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the radiofrequency ablation devices market in the forecast period.

Radiofrequency Ablation Devices Market Segment Analysis:

Radiofrequency Ablation Devices Market by Product Type (RF Generators, RF Catheters, RF Electrodes, and Others), by Application (Cardiology, Oncology, Pain Management, and Others), by End User (Hospitals, Specialty Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the radiofrequency ablation devices market, the RF catheters are estimated to account for a significant revenue share in the market for radiofrequency ablation devices. The auto-sizing capability of the RFA catheters help simplify and shorten circumferential RFA procedures. The through-the-scope certain RFA catheters also appears to simplify procedures in which limited focal radiofrequency ablation is needed and may reduce patient discomfort compared to over-the-scope type of catheters, which require multiple introductions of the endoscope. Thus, the factors mentioned above are going to be key contributors in the increasing demand for RFA catheters in the RFA Devices market during the forecast period.

North America is expected to dominate the Overall Radiofrequency Ablation Devices Market:

Among all the regions, North America is expected to account for the significant market share in the radiofrequency ablation devices market. North America is predicted to account for the dominant market share because of the high prevalence of chronic pain from various reasons such as low back pain, neck pain, and arthritis among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

The North America radiofrequency ablation devices market is witnessing an upward trend due to the rising prevalence of chronic low back pain among other factors. As per the data provided by the Centers for Disease Control and Prevention, in 2019, about 40 million US workers reported the problem of low back pain. Low back pain is one of the chief complaints that significantly affect the quality of life of patients. Radiofrequency ablation is often employed to interrupt pain signals in spinal nerves and is an emerging treatment option for chronic low back pain. Hence, the increasing patient pool of chronic low back pain may result in the growing demand for RFA devices, which in turn will boost the radiofrequency ablation devices market growth in the country as well as in the region.

As per the data provided by the Public Health Agency of Canada published in 2020, approximately 3.9 million (13.6%) Canadians over the age of 20 years live with diagnosed osteoarthritis. It has been reported in many studies that RFA procedures provide greater improvements in pain relief and knee function in patients suffering from osteoarthritis. Therefore, the increase in number of patients suffering from osteoarthritis in Canada is expected to drive the demand for RFA devices, thereby in the overall growth of the radiofrequency ablation devices market in the North American region.

The above-mentioned facts point towards the presence of diverse patient pool in the country as well as region that may benefit from the utilization of radiofrequency ablation devices. Furthermore, the well-established patient care system along with awareness among patients and caregivers regarding different types of radiofrequency ablation devices is further expected to propel the North American radiofrequency ablation devices market growth.

Moreover, the prompt and well-established healthcare services and infrastructure further contributes to the growth of the regional radiofrequency ablation devices market. The presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for radiofrequency ablation devices market. For instance, in February 2020, Boston Scientific Corporation received the product approval from the Canadian medical device regulatory authority, Health Canada for their IntellaNav StablePoint Ablation Catheter which is indicated to be used with in conjunction with a radio frequency (RF) generator for carrying out cardiac ablation.

Therefore, all the factors mentioned above would collectively contribute in the growth of the North America radiofrequency ablation devices market during the forecast period, ultimately driving the RF ablation devices market growth.

Radiofrequency Ablation Devices Market Key Players:

Some of the key market players operating in the radiofrequency ablation devices market includes BIOTRONIK Schweiz AG, Medtronic, Abbott, Olympus., Stryker, Boston Scientific Corporation, AngioDynamics., CONMED Corporation, Lepu Medical Technology (Beijing) Co.,Ltd, Arthrex, Inc., STARmed Co., Ltd., HOLOGIC, INC, Baylis Medical Company, Inc, Medical Devices Business Services, Inc.(Johnson & Johnson), Smith & Nephew, Sutter Medizintechnik GmbH, Bramsys, RF Medical Co., Ltd, OSYPKA AG, Avanos Medical, Inc., and others.

Recent Developmental Activities in Radiofrequency Ablation Devices Market:

In October 2022, Venclose Inc received the 510k clearance from the US Food and Drug Administration for their Maven endovenous radiofrequency ablation (RFA) catheter for minimally invasive treatment of incompetent perforator veins (IPVs).

In August 2020, Biosense Webster, a Johnson & Johnson Medical Devices Companies subsidiary, received European CE mark approval for their QDOT MICRO radiofrequency (RF) ablation catheter.

In February 2020, Avanos Medical Inc received the product approval from the US FDA for their 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion procedures.

Key Takeaways from the Radiofrequency Ablation Devices Market Report Study

Market size analysis for current radiofrequency ablation devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the radiofrequency ablation devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global radiofrequency ablation devices market.

Various opportunities available for the other competitor in the radiofrequency ablation devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current radiofrequency ablation devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for radiofrequency ablation devices market growth in the coming future?

Target Audience who can be benefited from this Radiofrequency Ablation Devices Market Report Study

Radiofrequency Ablation Devices products providers

Research organizations and consulting companies

Radiofrequency Ablation Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in radiofrequency ablation devices

Various End-users who want to know more about the radiofrequency ablation devices market and latest technological developments in the radiofrequency ablation devices market.

Frequently Asked Questions for Radiofrequency Ablation Devices Market:

1. What is a Radiofrequency Ablation Device?

Radiofrequency ablation devices are medical devices that provide an option of treating diseases such as arrhythmia and various cancers with the use of thermal energy under controlled temperatures.

2. What is the market for Global Radiofrequency Ablation Devices?

Global Radiofrequency Ablation Devices Market was valued at USD 3.64 billion in 2020, growing at a CAGR of 9.37% during the forecast period from 2024 to 2030 to reach USD 6.19 billion by 2030.

3. What are the drivers for Global Radiofrequency Ablation Devices Market?

The demand for radiofrequency ablation devices is witnessing growth due to the growing prevalence of chronic diseases such as cardiovascular diseases, cancers, rising geriatric population, and technological advancements in product development and design improvement.

4. Who are the key players operating in Global Radiofrequency Ablation Devices Market?

Some of the key market players operating in the radiofrequency ablation devices market includes BIOTRONIK Schweiz AG, Medtronic, Abbott, Olympus., Stryker, Boston Scientific Corporation, AngioDynamics., CONMED Corporation, Lepu Medical Technology (Beijing) Co.,Ltd, Arthrex, Inc., STARmed Co., Ltd., HOLOGIC, INC, Baylis Medical Company, Inc, Medical Devices Business Services, Inc.(Johnson & Johnson), Smith & Nephew, Sutter Medizintechnik GmbH, Bramsys, RF Medical Co., Ltd, OSYPKA AG, Avanos Medical, Inc., and others.

5. Which region has the highest share in Radiofrequency Ablation Devices market?

Among all the regions, North America is expected to account for the significant market share in the radiofrequency ablation devices market. North America is predicted to account for the dominant market share because of the high prevalence of chronic pain from various reasons such as low back pain, neck pain, and arthritis among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

Table of Contents

1.Radiofrequency Ablation Devices Market Report Introduction

2. Radiofrequency Ablation Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
    • 3.2.1 Germany
    • 3.2.2 France
    • 3.2.3 Italy
    • 3.2.4 Spain
    • 3.2.5 U.K.
  • 3.3 Japan

4. Radiofrequency Ablation Devices Market Key Factors Analysis

  • 4.1 Radiofrequency Ablation Devices Market Drivers
    • 4.1.1 Rising Prevalence of Cardiovascular Diseases
    • 4.1.2 Rising Prevalence of Cancers
    • 4.1.3 Rising Geriatric Population
    • 4.1.4 Increasing Focus on Innovative Product Development
  • 4.2 Radiofrequency Ablation Devices Market Restraints and Challenges
    • 4.2.1 Radiofrequency Ablation Procedure-Related Risks
    • 4.2.2 Limited Ablation Zone in Cancer Treatment
  • 4.3 Radiofrequency Ablation Devices Market Opportunities
    • 4.3.1 Addressing the Procedure-Related Limitations
    • 4.3.2 Product Improvement in Terms of Safety

5. Radiofrequency Ablation Devices Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Radiofrequency Ablation Devices Market

7. Radiofrequency Ablation Devices Market Layout

  • 7.1 By Product Type
    • 7.1.1 RF Generators
    • 7.1.2 RF Catheters
    • 7.1.3 RF Electrodes
    • 7.1.4 Others
  • 7.2 By Application
    • 7.2.1 Cardiology
    • 7.2.2 Oncology
    • 7.2.1 Pain Management
    • 7.2.2 Others
  • 7.3 By End User
    • 7.3.1 Hospitals
    • 7.3.2 Specialty Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Radiofrequency Ablation Devices Market, by Product Type
      • 7.4.1.2 North America Radiofrequency Ablation Devices Market, by Application
      • 7.4.1.2 North America Radiofrequency Ablation Devices Market, by End User
      • 7.4.1.4 North America Radiofrequency Ablation Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Radiofrequency Ablation Devices Market, by Product Type
      • 7.4.2.2 Europe Radiofrequency Ablation Devices Market, by Application
      • 7.4.2.2 Europe Radiofrequency Ablation Devices Market, by End User
      • 7.4.2.4 Europe Radiofrequency Ablation Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.2.6 Russia
      • 7.4.2.2.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Radiofrequency Ablation Devices Market, by Product Type
      • 7.4.3.2 Asia-Pacific Radiofrequency Ablation Devices Market, by Application
      • 7.4.3.2 Asia-Pacific Radiofrequency Ablation Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Radiofrequency Ablation Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Radiofrequency Ablation Devices Market, by Product Type
      • 7.4.4.2 RoW Radiofrequency Ablation Devices Market, by Application
      • 7.4.4.2 RoW Radiofrequency Ablation Devices Market, by End User
      • 7.4.4.4 RoW Radiofrequency Ablation Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Radiofrequency Ablation Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Radiofrequency Ablation Devices Market Company and Product Profiles

  • 9.1 BIOTRONIK Schweiz AG
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Medtronic
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Abbott
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Olympus
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Stryker
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Boston Scientific Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 AngioDynamics
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 CONMED Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Lepu Medical Technology (Beijing) Co.,Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Arthrex Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 STARmed Co., Ltd.,
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 HOLOGIC, INC
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Baylis Medical Company, Inc
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Medical Devices Business Services, Inc. (Johnson & Johnson)
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Smith & Nephew
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.16 Sutter Medizintechnik GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Bramsys
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 RF Medical Co., Ltd
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 OSYPKA AG
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Avanos Medical, Inc.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5 Entropy

10. PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Radiofrequency Ablation Devices Market
  • Table 3 Radiofrequency Ablation Devices Market in Global (2021-2030)
  • Table 4 Radiofrequency Ablation Devices Market in Global by Product Type (2021-2030)
  • Table 5 Radiofrequency Ablation Devices Market in Global by Application (2021-2030)
  • Table 6 Radiofrequency Ablation Devices Market in Global by End User (2021-2030)
  • Table 7 Radiofrequency Ablation Devices Market in Global by Geography (2021-2030)
  • Table 8 Radiofrequency Ablation Devices Market in North America (2021-2030)
  • Table 9 Radiofrequency Ablation Devices Market in North America by Product Type (2021-2030)
  • Table 10 Radiofrequency Ablation Devices Market in North America by Application (2021-2030)
  • Table 11 Radiofrequency Ablation Devices Market in North America by End User (2021-2030)
  • Table 12 Radiofrequency Ablation Devices Market in North America by Country (2021-2030)
  • Table 13 Radiofrequency Ablation Devices Market in the US (2021-2030)
  • Table 14 Radiofrequency Ablation Devices Market in Canada (2021-2030)
  • Table 15 Radiofrequency Ablation Devices Market in Mexico (2021-2030)
  • Table 16 Radiofrequency Ablation Devices Market in Europe (2021-2030)
  • Table 17 Radiofrequency Ablation Devices Market in Europe by Product Type (2021-2030)
  • Table 18 Radiofrequency Ablation Devices Market in Europe by Application (2021-2030)
  • Table 19 Radiofrequency Ablation Devices Market in Europe by End User (2021-2030)
  • Table 20 Radiofrequency Ablation Devices Market in Europe by Country (2021-2030)
  • Table 21 Radiofrequency Ablation Devices Market in France (2021-2030)
  • Table 22 Radiofrequency Ablation Devices Market in Germany (2021-2030)
  • Table 23 Radiofrequency Ablation Devices Market in the United Kingdom (2021-2030)
  • Table 24 Radiofrequency Ablation Devices Market in Italy (2021-2030)
  • Table 25 Radiofrequency Ablation Devices Market in Spain (2021-2030)
  • Table 26 Radiofrequency Ablation Devices Market in Russia (2021-2030)
  • Table 27 Radiofrequency Ablation Devices Market in Rest of Europe (2021-2030)
  • Table 28 Radiofrequency Ablation Devices Market in APAC (2021-2030)
  • Table 29 Radiofrequency Ablation Devices Market in APAC by Product Type (2021-2030)
  • Table 30 Radiofrequency Ablation Devices Market in APAC by Application (2021-2030)
  • Table 31 Radiofrequency Ablation Devices Market in APAC by End User (2021-2030)
  • Table 32 Radiofrequency Ablation Devices Market in APAC by Country (2021-2030)
  • Table 33 Radiofrequency Ablation Devices Market in China (2021-2030)
  • Table 34 Radiofrequency Ablation Devices Market in Japan (2021-2030)
  • Table 35 Radiofrequency Ablation Devices Market in India (2021-2030)
  • Table 36 Radiofrequency Ablation Devices Market in Australia (2021-2030)
  • Table 37 Radiofrequency Ablation Devices Market in South Korea (2021-2030)
  • Table 38 Radiofrequency Ablation Devices Market in Rest of APAC (2021-2030)
  • Table 39 Radiofrequency Ablation Devices Market in Rest of World (2021-2030)
  • Table 40 Radiofrequency Ablation Devices Market in RoW by Product Type (2021-2030)
  • Table 41 Radiofrequency Ablation Devices Market in RoW by Application (2021-2030)
  • Table 42 Radiofrequency Ablation Devices Market in RoW by End User (2021-2030)
  • Table 43 Radiofrequency Ablation Devices Market in RoW by Region (2021-2030)
  • Table 44 Radiofrequency Ablation Devices Market in Middle East (2021-2030)
  • Table 45 Radiofrequency Ablation Devices Market in Africa (2021-2030)
  • Table 46 Radiofrequency Ablation Devices Market in South America (2021-2030)

List of Figures

Figures 1 Competitive Analysis

Figures 2 COVID-19 Impact Analysis on Radiofrequency Ablation Devices Market

Figures 3 Radiofrequency Ablation Devices Market in Global (2021-2030)

Figures 4 Radiofrequency Ablation Devices Market in Global by Product Type (2021-2030)

Figures 5 Radiofrequency Ablation Devices Market in Global by Application (2021-2030)

Figures 6 Radiofrequency Ablation Devices Market in Global by End User (2021-2030)

Figures 7 Radiofrequency Ablation Devices Market in Global by Geography (2021-2030)

Figures 8 Radiofrequency Ablation Devices Market in North America (2021-2030)

Figures 9 Radiofrequency Ablation Devices Market in North America by Product Type (2021-2030)

Figures 10 Radiofrequency Ablation Devices Market in North America by Application (2021-2030)

Figures 11 Radiofrequency Ablation Devices Market in North America by End User (2021-2030)

Figures 12 Radiofrequency Ablation Devices Market in North America by Country (2021-2030)

Figures 13 Radiofrequency Ablation Devices Market in the US (2021-2030)

Figures 14 Radiofrequency Ablation Devices Market in Canada (2021-2030)

Figures 15 Radiofrequency Ablation Devices Market in Mexico (2021-2030)

Figures 16 Radiofrequency Ablation Devices Market in Europe (2021-2030)

Figures 17 Radiofrequency Ablation Devices Market in Europe by Product Type (2021-2030)

Figures 18 Radiofrequency Ablation Devices Market in Europe by Application (2021-2030)

Figures 19 Radiofrequency Ablation Devices Market in Europe by End User (2021-2030)

Figures 20 Radiofrequency Ablation Devices Market in Europe by Country (2021-2030)

Figures 21 Radiofrequency Ablation Devices Market in France (2021-2030)

Figures 22 Radiofrequency Ablation Devices Market in Germany (2021-2030)

Figures 23 Radiofrequency Ablation Devices Market in the United Kingdom (2021-2030)

Figures 24 Radiofrequency Ablation Devices Market in Italy (2021-2030)

Figures 25 Radiofrequency Ablation Devices Market in Spain (2021-2030)

Figures 26 Radiofrequency Ablation Devices Market in Russia (2021-2030)

Figures 27 Radiofrequency Ablation Devices Market in Rest of Europe (2021-2030)

Figures 28 Radiofrequency Ablation Devices Market in APAC (2021-2030)

Figures 29 Radiofrequency Ablation Devices Market in APAC by Product Type (2021-2030)

Figures 30 Radiofrequency Ablation Devices Market in APAC by Application (2021-2030)

Figures 31 Radiofrequency Ablation Devices Market in APAC by End User (2021-2030)

Figures 32 Radiofrequency Ablation Devices Market in APAC by Country (2021-2030)

Figures 33 Radiofrequency Ablation Devices Market in China (2021-2030)

Figures 34 Radiofrequency Ablation Devices Market in Japan (2021-2030)

Figures 35 Radiofrequency Ablation Devices Market in India (2021-2030)

Figures 36 Radiofrequency Ablation Devices Market in Australia (2021-2030)

Figures 37 Radiofrequency Ablation Devices Market in South Korea (2021-2030)

Figures 38 Radiofrequency Ablation Devices Market in Rest of APAC (2021-2030)

Figures 39 Radiofrequency Ablation Devices Market in Rest of World (2021-2030)

Figures 40 Radiofrequency Ablation Devices Market in RoW by Product Type (2021-2030)

Figures 41 Radiofrequency Ablation Devices Market in RoW by Application (2021-2030)

Figures 42 Radiofrequency Ablation Devices Market in RoW by End User (2021-2030)

Figures 43 Radiofrequency Ablation Devices Market in RoW by Region (2021-2030)

Figures 44 Radiofrequency Ablation Devices Market in Middle East (2021-2030)

Figures 45 Radiofrequency Ablation Devices Market in Africa (2021-2030)

Figures 46 Radiofrequency Ablation Devices Market in South America (2021-2030)

Figures 47 Market Drivers

Figures 48 Market Barriers

Figures 49 Marker Opportunities

Figures 50 PORTER'S Five Force Analysis